Thank You For Your Interest – Please Complete the Download Form
Over the past decade, pharmaceutical companies have navigated a growing number of regulations from different sources concerning the ethics of funding continuing medical education. The Sunshine Act currently under consideration would place even more pressure on companies to either leave CME alone or drastically scale back their involvement in funding activities.



